Articles From: Dreyfus High Yield Strategies Fund Semi-Annual Earnings Report for the Six-Month Period Ended September 30, 2014 to Viad Corp Announces Leadership Changes


Dreyfus High Yield Strategies Fund (NYSE:DHF) reported the following financial information for the six-month period ended September 30, 2014 compared with the results for the six-month period ended September 30, 2013: * Net Investment Income is calculated based on U.S. generally accepted accounting principles, whereas income distributions are determined in accordance with income tax regulations, which differ from U.S. generally accepted accounting principles.
Sign-up for Dreyfus High Yield Strategies Fund Semi-Annual Earnings Report for the Six-Month Period Ended September 30, 2014 investment picks
Casey’s General Stores, Inc. (Nasdaq: CASY) today reported diluted earnings per share of $1.28 for the second quarter of fiscal 2015 ended October 31, 2014, compared to $1.01 for the same quarter a year ago.
Sign-up for Casey’s Second Quarter Earnings Rise 26% investment picks
Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced four-year overall survival (OS) data from the ADCETRIS (brentuximab vedotin) pivotal Phase 2 clinical trial in relapsed or refractory systemic anaplastic large cell lymphoma (ALCL). ADCETRIS is an antibody-drug conjugate (ADC) directed to CD30, which is expressed in classical Hodgkin lymphoma (HL) and systemic ALCL, a type of T-cell lymphoma.
Sign-up for Seattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS® (Brentuximab Vedotin) Pivotal Trial in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma at ASH Annual Meeting investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0983503001&sourceType=1 http://media3.marketwire.com/logos/20121206-logo_orbite_200.jpg MONTREAL, QUEBEC --
Sign-up for Orbite Announces Change to its Board of Directors investment picks
Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced the presentation of preliminary data from the luspatercept phase 2 clinical trial in patients with beta-thalassemia at the 56 th American Society of Hematology (ASH) Annual Meeting and Exposition.
Sign-up for New Data from Luspatercept Phase 2 Clinical Trial in Beta-Thalassemia Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition investment picks
PBF Energy Inc. (NYSE:PBF) announced today that the company's management will be participating in meetings with institutional investors at the Wells Fargo Energy Symposium to be held in New York City on Wednesday, December 10, 2014.
Sign-up for PBF Energy to Attend Wells Fargo Energy Symposium investment picks
SANTA MONICA, Calif.
Sign-up for Douglas Emmett Increases Quarterly Cash Dividend investment picks
Bristol-Myers Squibb Company (NYSE:BMY) today announced positive results from a cohort of patients in its ongoing Phase 1b trial (CheckMate -039) which evaluated PD-1 immune checkpoint inhibitor, Opdivo (nivolumab), in patients with relapsed or refractory hematological malignancies (n=23). Results showed high levels of response in patients with relapsed or refractory classical Hodgkin Lymphoma (HL), with an overall response rate of 87% (n=20) and stable disease in 13% (n=3). These findings were published today in The New England Journal of Medicine ( NEJM ) and highlighted in the press briefing on Saturday, December 6 during the 56 th annual meeting of the American Society for Hematology (Abstract #289). In patients with HL, initial treatment typically consists of chemotherapy and/or radiation therapy, followed by an autologous stem cell
Sign-up for Opdivo (nivolumab) Demonstrates High Overall Response Rate of 87% for Treatment of Relapsed or Refractory Hodgkin Lymphoma investment picks
THE WOODLANDS, Texas , Dec.
Sign-up for Huntsman Announces Fourth Quarter 2014 Common Dividend investment picks
MINNEAPOLIS , Dec.
Sign-up for General Mills To Webcast Earnings Conference Call On Wednesday, December 17, 2014 investment picks
Equity LifeStyle Properties, Inc. (NYSE: ELS) (referred to herein as “we,” “us,” and “our”) today announced that we have entered into agreements to obtain approximately $395 million in new mortgage loans from institutional lenders, subject to customary approvals and conditions.
Sign-up for ELS Initiates Refinancing investment picks
CHICAGO , Dec.
Sign-up for CME Group Inc. Declares Annual Variable Dividend of $2.00 per Share investment picks
RESTON, Va.
Sign-up for Leidos Holdings, Inc. Declares Quarterly Cash Dividend investment picks
Mackenzie Master Limited Partnership announces estimate of distribution of partnership income Canada NewsWire TORONTO , Dec.
Sign-up for Mackenzie Master Limited Partnership announces estimate of distribution of partnership income investment picks
SAN DIEGO , Dec.
Sign-up for Sempra Energy Declares Common Dividend investment picks
American Express (NYSE:AXP) today announced a $1 million grant to the Trust for the National Mall to preserve and restore the 178-year old Lockkeeper’s House, the oldest existing structure on the National Mall in Washington, D.C. The Lockkeeper’s House stands as a rare artifact of early 19 th -century Washington, D.C. when commerce was conducted via a system of canals designed to transport goods connecting the Capital to the Nation.
Sign-up for American Express Announces $1 Million Grant to Trust for the National Mall to Restore Historic Lockkeeper’s House investment picks
HONOLULU , Dec.
Sign-up for Alexander & Baldwin Announces Sales At Its Maui Business Park II Project investment picks
Google (GOOGL) is planning to launch kid-friendly versions of its Chrome browser, YouTube music streaming service and other products in 2015, Google confirmed to MarketWatch on Thursday.
Sign-up for UPDATE: Google to launch kid-friendly Chrome, YouTube investment picks
Steven W.
Sign-up for Viad Corp Announces Leadership Changes investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Dreyfus High Yield Strategies Fund Semi-Annual Earnings Report for the Six-Month Period Ended September 30, 2014 to Viad Corp Announces Leadership Changes
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent